| 标题 |
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Philippe Moreau; Michel Attal; Cyrille Hulin; Bertrand Arnulf; Karim Belhadj; et al 出版日期:2019-06-03 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)